These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 1357029)
41. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection. Arinola OG; Louis JS; Tacchini-Cottier F; Aseffa A; Salimonu LS Afr J Med Med Sci; 2005 Mar; 34(1):65-70. PubMed ID: 15971557 [TBL] [Abstract][Full Text] [Related]
42. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Gessner A; Blum H; Röllinghoff M Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519 [TBL] [Abstract][Full Text] [Related]
43. Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice. Sommer F; Meixner M; Mannherz M; Ogilvie AL; Röllinghoff M; Lohoff M Int Immunol; 1998 Dec; 10(12):1853-61. PubMed ID: 9885906 [TBL] [Abstract][Full Text] [Related]
44. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Varkila K; Chatelain R; Leal LM; Coffman RL Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179 [TBL] [Abstract][Full Text] [Related]
45. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. Bihl F; Pecheur J; Bréart B; Poupon G; Cazareth J; Julia V; Glaichenhaus N; Braud VM J Immunol; 2010 Aug; 185(4):2174-81. PubMed ID: 20624944 [TBL] [Abstract][Full Text] [Related]
47. Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection. Buxbaum LU Parasite Immunol; 2010 Feb; 32(2):153-60. PubMed ID: 20070829 [TBL] [Abstract][Full Text] [Related]
48. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. Ronet C; Hauyon-La Torre Y; Revaz-Breton M; Mastelic B; Tacchini-Cottier F; Louis J; Launois P J Immunol; 2010 Jan; 184(2):886-94. PubMed ID: 19966209 [TBL] [Abstract][Full Text] [Related]
49. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Heinzel FP; Sadick MD; Mutha SS; Locksley RM Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7011-5. PubMed ID: 1908085 [TBL] [Abstract][Full Text] [Related]
50. Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Kelso A; Groves P; Troutt AB; Francis K Eur J Immunol; 1995 May; 25(5):1168-75. PubMed ID: 7774620 [TBL] [Abstract][Full Text] [Related]
51. Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro. Kelso A; Troutt AB; Maraskovsky E; Gough NM; Morris L; Pech MH; Thomson JA Immunol Rev; 1991 Oct; 123():85-114. PubMed ID: 1684785 [TBL] [Abstract][Full Text] [Related]
52. Differential response of antigen presenting cells from susceptible and resistant strains of mice to Taenia crassiceps infection. Reyes JL; Terrazas CA; Vera-Arias L; Terrazas LI Infect Genet Evol; 2009 Dec; 9(6):1115-27. PubMed ID: 19465163 [TBL] [Abstract][Full Text] [Related]
53. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells. Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108 [TBL] [Abstract][Full Text] [Related]
54. Natural killer cells participate in the early defense against Leishmania major infection in mice. Laskay T; Röllinghoff M; Solbach W Eur J Immunol; 1993 Sep; 23(9):2237-41. PubMed ID: 8370404 [TBL] [Abstract][Full Text] [Related]
55. PKCδ regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis. Guler R; Afshar M; Arendse B; Parihar SP; Revaz-Breton M; Leitges M; Schwegmann A; Brombacher F Eur J Immunol; 2011 Mar; 41(3):706-15. PubMed ID: 21287553 [TBL] [Abstract][Full Text] [Related]
56. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes. Bogdan C; Stenger S; Röllinghoff M; Solbach W Eur J Immunol; 1991 Feb; 21(2):327-33. PubMed ID: 1900240 [TBL] [Abstract][Full Text] [Related]
57. Early parasite containment is decisive for resistance to Leishmania major infection. Laskay T; Diefenbach A; Röllinghoff M; Solbach W Eur J Immunol; 1995 Aug; 25(8):2220-7. PubMed ID: 7664785 [TBL] [Abstract][Full Text] [Related]
58. Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Morris L; Troutt AB; McLeod KS; Kelso A; Handman E; Aebischer T Infect Immun; 1993 Aug; 61(8):3459-65. PubMed ID: 8335376 [TBL] [Abstract][Full Text] [Related]
59. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. Will A; Blank C; Röllinghoff M; Moll H Eur J Immunol; 1992 Jun; 22(6):1341-7. PubMed ID: 1601029 [TBL] [Abstract][Full Text] [Related]
60. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity. Titus RG; Müller I; Kimsey P; Cerny A; Behin R; Zinkernagel RM; Louis JA Eur J Immunol; 1991 Mar; 21(3):559-67. PubMed ID: 1672641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]